| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.makerslabs.com | |
| Market Cap | 82.49 Cr. | |
| Enterprise Value(EV) | 92.16 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -8.91 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.01 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 109.63 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.28 | Calculated using Price: 139.80 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.59 Cr. | 5,900,376 Shares |
| FaceValue | 10 | |
| About Makers Laboratories Ltd. | ||
| Makers Laboratories was incorporated in 1985. The company is promoted and managed by Ipca Laboratories group. The company is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The company's plants are located in Palghar and Dombivli in Thane (Maharashtra). The company has a prominent presence in the therapeutic segment of antibiotics. | ||
| 1 Day |
|
+0.80% |
| 1 Week |
|
+10.14% |
| 1 Month |
|
+15.07% |
| 3 Month |
|
+0.22% |
| 6 Month |
|
+20.45% |
| 1 Year |
|
+23.17% |
| 2 Year |
|
-19.12% |
| 5 Year |
|
+165.83% |
| 10 Year |
|
+633.51% |
| 3 years | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 2.49 | 20.61 | -3.4 | |
| Return on Capital Employed (%) | 6.53 | 24 | 1.72 | |
| Return on Assets (%) | 0.99 | 8.35 | -1.48 |
| Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 54 | 60 | 69 | 66 | |
| Non Curr. Liab. | 17 | 13 | 15 | 17 | |
| Curr. Liab. | 33 | 33 | 28 | 30 | |
| Minority Int. | 32 | 39 | 40 | 40 | |
| Equity & Liab. | 136 | 144 | 152 | 154 | |
| Non Curr. Assets | 75 | 81 | 89 | 89 | |
| Curr. Assets | 61 | 63 | 63 | 64 | |
| Misc. Exp. not W/O | |||||
| Total Assets | 136 | 144 | 152 | 154 |
| Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 69 | 127 | 101 | 106 | |
| Other Income | 1 | 3 | 2 | 1 | |
| Total Income | 70 | 130 | 104 | 107 | |
| Total Expenditure | -61 | -108 | -98 | -104 | |
| PBIDT | 9 | 21 | 6 | 3 | |
| Interest | -2 | -2 | -2 | -2 | |
| Depreciation | -5 | -4 | -4 | -5 | |
| Taxation | -1 | -4 | -1 | 0 | |
| Exceptional Items | 0 | ||||
| PAT | 1 | 12 | -2 | -4 | |
| Minority Interest | -2 | -7 | -3 | -2 | |
| Share Associate | |||||
| Other Related Items | |||||
| Consolidated Net Profit | 0 | 5 | -5 | -5 | |
| Adjusted EPS | -1 | 10 | -8 | -9 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 19 | -9 | ||
| Cash Fr. Inv. | -22 | 1 | ||
| Cash Fr. Finan. | 0 | 6 | ||
| Net Change | -3 | -2 | ||
| Cash & Cash Eqvt | 2 | 1 |
|
Wed, 10 Apr 2024
Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations 2015. Pursuant to Regulation 7(3) of the SEBI(LODR) Regulations 2015 we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1 2023 to March 31 2024 (both days inclusive) by the Companys Registrar and Share Transfer Agent viz. Link Intime India Private Limited which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058. |
|
Tue, 09 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 31st March 2024. |
|
Fri, 22 Mar 2024
Closure of Trading Window Closure of Trading Window |
| Thu, 18 Apr 2024 |
High Delivery Percentage
|
Close Within 52 Week High Zone
|
Making Higher Highs for 2 Days
|
High Increase in 1 Month
|
High Increase in 5 Years
|
